Journal Club- November 2026
The Tunneled Coronally Advanced Flap (TCAF) for Root Coverage Procedures: Rationale, Indications, and a Novel Papilla-Based Decision Tree. Tavelli L, Barootchi S. J Periodontal Res. 2026 Jul 4. doi: 10.1111/jre.70147. Epub ahead of print. PMID: 42400352.
One-Year Outcomes of Chairside Fully Guided Versus Conventional Partially Guided Implant Placement With Transcrestal Sinus Augmentation: A Randomized Controlled Trial. Lee, J., Y.-W. Baek, J. Kim, et al. 2026.Clinical Oral Implants Research 1–16. doi: 10.1111/clr.70189.
Connective tissue graft wall technique for mandibular Class II furcation defects: Two case reports. Mounssif, I et al. Clin Adv Periodontics. 2026 Sep 12. doi: 10.1002/cap.70096. PMID: 42730603.
Peri-implantitis—Is it mainly a clinician-initiated complication of implant therapy? Chen ST, Monje A, Strauss FJ, Schwarz F, Roccuzzo A, Sailer I, Tarnow D, Lambert F, Jovanovic S, Buser D. Periodontol 2000. 2026 Jun 8. doi: 10.1111/prd.70051. PMID: 42253157.
Impact of Early Occlusal Therapy in Stage III and IV Periodontitis: A Prospective Cohort Study. Gianserra R, La Rocca M, Gianserra V, Gianserra N, Sbordone L. J Periodontal Res. 2026 Oct 1. doi: 10.1111/jre.70174. Epub ahead of print. PMID: 42817745.
Modified palatal strip grafting for keratinized tissue augmentation: A technical report. Clin Adv Periodontics. Yadav VS, Ali M, Ilango A, Dharani K. 2026 Oct 6. doi: 10.1002/cap.70102. Epub ahead of print. PMID: 42839585.
Soft-Tissue Integration of Dental Implants: Formation, Maintenance, and Relevance for Peri-Implant Health. Aellos F, Clavelier A, Liu B, Wan A, Salvi GE, Romandini M, Helms JA. J Periodontal Res. 2026 Mar 26. doi: 10.1111/jre.70091.
Autologous Bone for Periodontal and Craniofacial Regeneration: Donor Sites, Characteristics and Indications. Palombo D, Ríos-Barbero J, Conforti T, Chiapasco M. J Periodontal Res. 2026 Jan 28. doi: 10.1111/jre.70065.
Self-Reported Penicillin Allergy, Alternative Antibiotics, and Implant Outcomes: A Retrospective Study. Fetner A, Vilela N, Lu X, Shan G, Duarte PM. Clin Implant Dent Relat Res. 2026 Aug;28(4):e70169. doi: 10.1111/cid.70169. PMID: 42454622; PMCID: PMC13370837.
Patient-Reported Outcome Measures (PROMs) in Sinus Elevation Procedures: A Systematic Review and Meta-analysis. Menini M, Canullo L, Pesce P, Bixio F, Bagnasco F, Del Fabbro M. Int J Oral Maxillofac Implants. 2026 Sep 30;41(5):557-566. doi: 10.11607/jomi.11434. PMID: 40553622.
Treatment of Small Peri-Implant Buccal Dehiscence Defects With SCTG or GBR: 3-Year Results of a Pilot Study. Zuercher AN, Rusch F, Strauss FJ, Jung RE, Lim HC, Thoma D. Clinical Implant Dentistry and Related Research 28, no. 6 (2026): e70192, doi: 10.1111/cid.70192.
Effect of Crestal Soft-Tissue Augmentation Prior to or Simultaneously With Implant Placement on Peri-Implant Tissue Dimensions: Histological Outcomes of an Experimental In Vivo Study. Zhang Y, Park SY, Yoo SH, et al. 2026. Journal of Clinical Periodontology 1–11. doi: 10.1111/jcpe.70211.
Residual Periodontal Pockets at Implant Placement as Risk Indicator for Peri-Implantitis: A Systematic Review. Ferrarotti F, Baima G, Campagna A, Corana M, Cafasso E, Chuachamsai S, Llerena-Velasquez M, Mariani GM, Aimetti M. Clin Implant Dent Relat Res. 2026 Aug;28(4):e70174. doi: 10.1111/cid.70174. PMID: 42515938; PMCID: PMC13408331.
The Long-Term Impact of Single Implant-Supported Crowns on Adjacent Natural Teeth: A Retrospective Longitudinal Study. Shao J, Butt QO, Tsai CL, Man H, Chaudhry H, Lodhi MK, Wang HL.Clin Oral Implants Res. 2026 Sep 24. doi: 10.1111/clr.70180. Epub ahead of print. PMID: 42786608.
Application of Biologics in Maxillary Sinus Augmentation Surgery: A Narrative Review. Aghaloo T, Valentini P, Yardley R, Zadeh HH. Clin Implant Dent Relat Res. 2025 Jun;27(3):e70004. doi: 10.1111/cid.70004. PMID: 40471092.
Palatal donor site wound healing following mucogingival surgery using amnion–chorion membrane: A randomized controlled clinical trial. Yineman KJ, Palaiologou AA, Powell CA, Deas DE, Mealey BL. J Periodontol. 2026; 97: 1900–1909. doi: 10.1002/jper.70147
Timing of Re-Evaluation After Periodontal Therapy: A Randomized Clinical Trial. Castelluzzo W, Rupe C, Nieri M, di Martino M, Zini M, Sartori A, Tasco A, Spoleti F, Barbato L, Cairo F. J Periodontal Res. 2026 May;61(5):560-571. doi: 10.1111/jre.70086. Epub 2026 Feb 10. PMID: 41664833; PMCID: PMC13378204.
Association Between Local Factors and Implant-Related Complications: A Population-Sampled Cross-Sectional Analysis. Mauland, E. K., D. F. Bunæs, S.-A. Lie, and A. Verket. 2026. Journal of Clinical Periodontology 1–14. doi: 10.1111/jcpe.70209.
Abstracts:
Topic: Root Coverage
Author: Tavelli et al.
Title: The Tunneled Coronally Advanced Flap (TCAF) for Root Coverage Procedures: Rationale, Indications, and a Novel Papilla-Based Decision Tree.
<Source: J Periodontal Res. 2026 Jul 4.
DOI: 10.1111/jre.70147
Type: Decision tree
Keywords: decision tree, gingival recession, papilla, root coverage, tunneled coronally advanced flap (TCAF)
Purpose: To establish a site-specific clinical decision-making algorithm for root coverage utilizing the Tunneled Coronally Advanced Flap (TCAF).
Background: While Coronally Advanced Flaps (CAF) and Tunneling (TUN) yield comparable root coverage—governed by clinical attachment loss (CAL), keratinized tissue width (KTW), gingival thickness (GT), and plaque control—TUN minimizes tissue trauma and preserves perfusion, but restricts surgical exposure. Conversely, traditional CAF provides access at the expense of papilla disruption. TCAF combines the vascular advantages of tunneling with selective papilla opening driven by defect morphology.
The Primary Indications are: Multiple adjacent recessions with interproximal CAL or narrow papillae; isolated recessions adjacent to a deficient papilla; rotated teeth; uneven esthetic zone defects; shallow mandibular anterior vestibules; mandibular premolar sites (protecting the mental nerve); lingual recessions; and simultaneous soft tissue + papilla augmentation.
Defining the TCAF Framework:A procedure qualifies as TCAF under three conditions: 1) Site-by-site interproximal papilla evaluation. 2)Inclusion of at least one tunneled papilla : and at least one open papilla (distinguishing it from pure TUN or pure CAF). 3) Coronal advancement utilizing de-epithelialized papillae as vascular receipt beds.
The surgical design permits variable vertical releasing incisions and a customized split-full-split flap thickness.A Papilla-Based Decision Tree Algorithm was formulated. Clinical decision-making relies on three diagnostic criteria for Papilla Fill. The interproximal CAL & CEJ relationships are as follows:
Flat- (Tip at CEJ level): TCAF (Tunnel papilla).
Medium- (Tip coronal to CEJ), below contact point; black triangle present):
Narrow angle (<30°): Tunnel.
Wide angle (> 30°) + shallow recession (< 4mm): Tunnel.
Wide angle (>30°) + deep recession (>4mm):: Tunnel or CAF.
Full- (Fills interproximal space completely):
Narrow angle (<30°): Tunnel.
Wide angle (>30°) + shallow recession (< 4mm): Tunnel or CAF.
Wide angle (>30°) + deep recession (>4mm): CAF (Open papilla).
Papilla Angle: Narrow angles (<30°) have limited perfusion and higher post-op shrinkage, favoring tunneling over surgical reflection. Wide angles provide higher vascular flow.
Recession Depth: Shallow or multi-adjacent recessions benefit from tunneling mobility, whereas deep isolated defects may require full CAF exposure.
Surgical Sequence & Technique
- Execution Sequence: Perform TUN first, CAF second, and Vertical Release last (if required) to safeguard collateral circulation and minimize trauma.
- Tunnel Preparation: Microsurgical sulcular incision creating a full-thickness tunnel, transitioning to split-thickness apical to the mucogingival junction (MGJ). Unopened papillae are elevated interproximally (extending palatally/lingually if augmenting papilla height).
- Open Papilla Preparation: Papillae designated for CAF are elevated via split-thickness to provide a vascular recipient bed within a overall split-full-split flap architecture.
- Grafting & Suturing: A subepithelial connective tissue graft (SCTG) is positioned across both tunneled and open segments and stabilized with tension-free sling sutures.
Conclusion: TCAF provides an anatomy-driven hybrid protocol optimizing vascular preservation and flap mobility for complex root coverage scenarios.
Topic: Guided implant placement
Author: Lee et al.
Title: One-Year Outcomes of Chairside Fully Guided Versus Conventional Partially Guided Implant Placement With Transcrestal Sinus Augmentation: A Randomized Controlled Trial
Source: Clinical Oral Implants Research, 2026; 0:1–16
DOI: 10.1111/clr.70189
Reviewer: Jack Cooper
Type: RCT
Keywords: accuracy, flapless surgery, guided implant placement, sinus augmentation
Purpose: To evaluate the results at one year follow-up of a randomized controlled trial where fully guided flapless implant placement was used versus conventionally partially guided, open flap implant placement in conjunction with transcrestal sinus augmentation. Specifically, results pertaining to marginal bone loss and peri-implant tissue outcomes.
Background: Implant malpositioning can create extreme complications in patients which can lead to failures such as fractures or screw loosening. Attaining positional accuracy is paramount for ideal restorative longevity. Fully guided implant systems have risen within the industry as a method of maintaining positional accuracy, even through simple chairside, light-cured methods. Whether guided implant placement enables adequate marginal bone levels over time has yet to be examined thoroughly.
Materials/Methods: This randomized controlled trial examined utilized 56 patients for eligibility and allocated a split of 28 vs. 28 either in the partially guided open-flap surgery group (PG) or the fully guided flapless surgery group with a light-cured surgical guide (FG). At one year follow-up, 22 patients remained in PG (four discontinued) and 21 in FG (5 discontinued mainly due to osseointegration failures). The tissue-level implants were placed in the posterior maxilla with crestal sinus floor elevation. The PG cohort had a lab-made partial stent and utilized midcrestal incisions with elevation and freehand placement. The FG cohort had a chairside light-cured fully guided stent with a surgical soft tissue punch and guided placement. Post-placement intraoral scanning was used for analysis of placement accuracy and superimposed on the initial planned design. Emergence angle and emergence profile were both evaluated. Additionally, probing depth (PD), recession (REC), plaque index (PI), bleeding on probing (BOP), keratinized tissue (KT), and vestibular depth were evaluated. Marginal bone losses were calculated radiographically.
Results: Implant survival for both groups was very high with 92.9% in PG and 89.3% in FG. Most failures were due to osseointegrative failures and lack of primary stability. Prosthetic deliveries occurred at similar times between the two cohorts and emergence angles and profiles were relatively similar. Mesial angle value was 38.41⁰ and distal angle value was 43.08⁰ for the PG group while mesial was 39.31⁰ and distal was 43.93⁰ for FG group.
With clinical parameters, no statistical significances were noted. PD was 2.92 mm in PG and 2.80 mm in FG. Recession was small and non-significant. BOP percentages were low with 8.3% in PG and 6.7% in FG. KT and vestibular depth were also similar for both groups as well. With marginal bone loss, no differences were seen between the two groups at the one year follow-up. The FG group did have greater mesial value compared to the PG cohort (0.51 mm vs. -0.12 mm). Mean difference in MBL was 0.04 mm in PG and 0.48 mm in FG. With regression analysis, greater distal emergence angles and 3D platform deviation were statistically significant for mesial marginal bone loss. Vertical apical deviation was overall significant for marginal bone loss. No peri-implantitis was noted at one year follow-up for either group.
Discussion: Both groups showcased favorable peri-implant clinical parameters at one-year follow-up. While FG showcased greater positive mesial marginal bone values, with Holm adjustment these were deemed non-significant. With a mean emergence angle of greater than 30 degrees and an overall convex profile, marginal bone levels were stable with functional loading. While previous studies have shown that fully guided procedures may have 1-2 mm greater accuracy compared to free-hand, they can also be time consuming and costly. The transmucosal implant design may have enabled less prosthetic load on the crestal bone, preventing resorption.
Conclusion: While fully guided, flapless, chairside implant placement enabled better placement accuracy and short-term marginal bone preservation, there were very few differences in the outcomes of peri-implant soft tissue health compared to a partially guided, surgical implant placement.
Topic: Management of furcation defects with connective tissue graft wall technique.
Author: Mounssif, I et al.
Title: Connective tissue graft wall technique for mandibular Class II furcation defects: Two case reports.
Source: Clinical Advances in Periodontics 2026; e70096: 1–8.
DOI: 10.1002/cap.70096.
Reviewer: Ahmed Fawzy.
Type: Case Series.
Keywords: connective tissue graft, enamel matrix derivative, furcation defects, periodontal pocket.
Purpose: To describe the application and clinical and radiographic outcomes (18 month followup ) of the connective tissue graft wall technique combining coronally advanced flap (CAF), CTG and enamel matrix derivative (EMD) for treating mandibular Class II furcation defects with or without gingival recession.
Materials and Methods:
Study Population & Patient Selection: Evaluated two systemically healthy patients presenting with deep periodontal pockets and Class II, subclass B buccal furcation defects on mandibular first right molars (tooth #46).
Case 1: 53-year-old non-smoking female with localized Stage III, Grade B periodontitis and coexisting 1 mm buccal gingival recession.
Case 2: 50-year-old smoking male with generalized Stage III, Grade C periodontitis, cervical enamel projection (CEP), and no baseline recession.
Surgical Protocol (CTG Wall Technique):1) Elevated a trapezoidal coronally advanced flap (CAF) using a split-full-split thickness dissection sequence to achieve passive coronal advancement coronal to the CEJ. 2) Debrided granulation tissue, removed CEP , root planed, and conditioned dentin with 24% EDTA gel for 2 minutes before applying EMD. 3) Harvested a 1mm thick deepithelialized palatal FGG and positioned it as a soft tissue wall over the furcation defect, suturing it coronally to adjacent papillae and apically to the periosteum with 7-0 PGA. 4) Secured the CAF over the CTG using 6-0 PGA sling sutures. 5) Postoperative care included chlorhexidine mouthrinse and 3-month supportive periodontal maintenance.
Evaluated Parameters: Monitored at baseline and 18 months post-surgery for: 1) Probing Pocket Depth. 2) Horizontal Probing Depth. 3) Clinical Attachment Level. 4) Recession. 5) Bleeding on Probing. 6) Keratinized Tissue Width. 7) Hamp Class furcation involvement. 8) Radiographic interradicular bone fill.
Results: Furcation Closure: Both cases achieved complete furcation resolution at 18 months, converting from Class II FI at baseline to Class 0 (closed furcation, no horizontal penetration with a Nabers probe).
Probing Depth & Clinical Attachment Gain: – Case 1: Buccal PD reduced from 7 mm to 3 mm, CAL improved from 8 mm to 3 mm, buccal recession resolved from 1 mm to 0 mm (100% root coverage).
– Case 2: Buccal PD reduced from 7 mm to 4 mm, CAL improved from 7 mm to 4 mm, gingival margin remained stable with 0 mm recession. Clinical & Radiographic Parameters: BOP completely resolved in both cases. Periapical and bitewing radiographs at 18 months demonstrated trabecular bone reestablishment and bone fill within the interradicular furcation area.
Conclusion: Combining a coronally advanced flap, connective tissue graft, and EMD via the CTG wall technique successfully resolved mandibular Class II furcation defects while achieving significant clinical attachment gain and soft tissue stability. Serving as a vascularized, biological soft-tissue barrier, the CTG optimizes space maintenance, clot stability, and tissue phenotype, protecting the regenerative compartment without requiring adjunctive bone grafting materials.
Topic: Peri-implantitis Etiology and Associations.
Author: Chen, ST, et al.
Title: Peri-implantitis: Is it mainly a clinician-initiated complication of implant therapy?
Source: Periodontology 2000 2026; 00: 1–32.
DOI: 10.1111/prd.70051.
Reviewer: Ahmed Fawzy.
Type: Review Article.
Keywords: Clinician-related errors, iatrogenic complications, micro-rough implant surfaces, peri-implantitis, prosthodontic errors, surgical errors.
Purpose: To review evidence linking clinician initiated surgical and prosthetic errors to the exposure of micro-rough implant surfaces to the periimplant sulcus, advocating for a paradigm shift toward a complication based model of peri-implantitis and outlining evidence-based preventive protocols.
Materials and Methods: Design & Concept: A narrative review synthesized clinical, preclinical, and epidemiological literature examining iatrogenic triggers of peri-implantitis.
Evaluated Factors: 1) Causative/Predisposing Primary Factor: Exposure of the micro-rough implant surface to the peri-implant sulcus, leading to rapid biofilm accumulation and aggressive inflammatory tissue responses. 2) Surgical Risk Factors: Reduced alveolar crest width, avascular necrosis, incomplete bone regeneration in post-extraction and healed defects, and multi-directional implant malposition (buccal, mesiodistal/implant proximity, coronal, and apical). 3)Prosthetic Risk Factors: Excessive restorative emergence angles (EA > 30-40 degrees), subgingival retained cement remnants, and platform-matching vs. platform-switching designs.4) Influencing Co-Factors: Patient education/compliance, history of periodontitis, systemic factors/habits (ex. smoking, uncontrolled diabetes), lack of keratinized peri-implant mucosa (KM <2mm), prosthetic misfit, overcontoured/uncleansable prostheses, and inadequate supportive peri-implant care (SPIC).
Results: Paradigm Shift & Etiology: Up to 71.2% of peri-implantitis cases are triggered by clinician-related surgical (40.8%) and prosthetic (30.4%) factors, whereas only 28.8% are purely plaque-induced.
1) Implant Design & Surface Characteristics: A) Non-hybrid implants featuring micro-rough surfaces extending to the shoulder demonstrate significantly higher 10-year peri-implantitis rates (11.8% to 33%) and overall complication rates compared to hybrid surface designs (e.g., Tissue Level implants with a smooth/machined transmucosal neck), which exhibit 10-year peri-implantitis rates of only (1.8%) and 25-year success rates of 90.8%. B) Subcrestal placement of the micro-rough surface (approx. 1 mm) acts as a safety buffer against early crestal bone loss (CBL). Platform-switching (PS) with stable conical connections significantly minimizes early CBL compared to platform-matching interfaces. 2) Surgical Outcomes: A) Buccal bone wall thickness (BBT) < 1.5-2mm triggers avascular necrosis post-flap elevation, leading to 8X-12X greater vertical CBL and facial dehiscence defects. B) Immediate implant placement (Type 1) yields unpredictable complete bone fill (21%-57%), leaving exposed micro-rough surfaces in 47% of cases exhibiting ≥1mm mucosal recession at 5 years. Early placement (Type 2) with a 2-layer composite graft achieves predictable 2-wall defect regeneration. C) Buccally malpositioned implants carry a 3X-8X higher risk of peri-implantitis, while inter-implant proximity < 3 mm increases exposure risk by 8.6 times due to lateral bone loss. D) Apical malposition > 6mm from adjacent CEJs) increases peri-implantitis risk by 8.5X. 3) Prosthetic Outcomes: A) Wide emergence angles (> 30-40 degrees) on bone-level implants directly cause early CBL, remaking restorations with longer abutments and narrower angles can reverse CBL and induce bone remineralization. B) Intraoral cementation results in retained cement in up to 72.5% of cases (especially with submucosal margins > 0.5 mm), acting as an unresolvable foreign-body and plaque-retentive factor. C) Lack of KM (<2mm), convex emergence profiles (>40 degree) and uncleanable over contoured restorations significantly increase plaque retention, bleeding on probing, mucosal recession, and progressive bone loss.
Conclusion: The vast majority of peri-implantitis cases are preventable, iatrogenic complications stemming from clinician errors rather than classical, unprovoked disease. Primary prevention mandates avoiding exposure of the micro-rough surface by selecting hybrid surface designs, placing bone-level implants subcrestally, ensuring adequate bone wall thickness (≥ 1.5mm), avoiding cement-retained prostheses, designing restorations with narrow emergence angles (EA < 30- 40 degrees) and concave profiles, preserving ≥ 2mm of keratinized mucosa, and enforcing tailored, risk stratified supportive peri-implant care.
Topic: Occlusal therapy in periodontitis
Authors: Gianserra R, et al.
Title: Impact of Early Occlusal Therapy in Stage III and IV Periodontitis: A Prospective Cohort Study
Source: Journal of Periodontal Research. 2026; Advance online publication.
DOI: 10.1111/jre.70174
Type: Prospective cohort study / Research letter
Reviewer: Marcelo Galindo
Keywords: Periodontitis, occlusal therapy, tooth mobility, splinting, occlusal adjustment, periodontal treatment
Purpose: To evaluate the effect of early occlusal therapy (OT), consisting of splinting and occlusal adjustment, on periodontal healing in patients with Stage III and IV periodontitis.
Material and Methods: Forty-nine patients with Stage III or IV periodontitis and at least one tooth with Miller Class 1, 2, or 3 mobility were included, for a total of 56 teeth. Teeth were allocated to a Test group receiving occlusal therapy (OT) combined with subgingival instrumentation (SI) (33 teeth), or a Control group receiving SI alone (23 teeth). Group allocation was not randomized, with teeth presenting greater mobility and functional discomfort assigned to the Test group, while seven patients contributed one tooth to each group in a split-mouth design.
All patients received professional mechanical plaque removal (PMPR) and oral hygiene instructions, followed by SI completed within a 2-week period. In the Test group, OT was performed after PMPR and before SI, consisting of composite splinting of mobile teeth and occlusal adjustment to eliminate premature contacts. Composite was applied to enamel surfaces, leaving root surfaces free to maintain access for subgingival instrumentation and plaque control. Clinical attachment level (CAL), probing depth (PD), bleeding on probing (BOP), and plaque index (PI) were evaluated at baseline and 90 days after SI.
Results: All 56 teeth completed the 90-day follow-up, with greater baseline mobility observed in the Test group. OT was associated with significantly greater CAL gain and PD reduction compared with SI alone, with an adjusted additional improvement of 1.05 mm in CAL and 0.91 mm in PD.
BOP improvement was also significantly greater in the OT group, while plaque resolution was comparable between groups.
Conclusion: Early occlusal therapy with splinting and occlusal adjustment before subgingival instrumentation was associated with greater short-term CAL gain, PD reduction, and BOP improvement in patients with Stage III and IV periodontitis. These findings should be interpreted cautiously due to the nonrandomized study design.
Topic: Keratinized tissue augmentation
Authors: Yadav VS, et al.
Title: Modified palatal strip grafting for keratinized tissue augmentation: A technical report
Source: Clinical Advances in Periodontics. 2026;e70102.
DOI: 10.1002/cap.70102
Type: Technical report
Reviewer: Marcelo Galindo
Keywords: Keratinized tissue, free gingival graft, palatal strip graft, vestibular deepening, mucogingival surgery
Purpose: To describe a modified palatal strip graft (mPSG) technique for keratinized tissue (KT) augmentation around teeth using a single narrow palatal graft without additional biomaterials.
Surgical Technique: The technique was demonstrated in three clinical cases presenting with insufficient attached gingiva, primarily in the mandibular anterior region. A horizontal incision was performed slightly coronal to the mucogingival junction within the existing KT, or at the gingival margin when KT was absent, followed by two vertical incisions extending into the alveolar mucosa. Partial-thickness dissection was performed at different depths to create three recipient bed zones. Zone 1 consisted of a 3 mm wide coronal area with a thin layer of connective tissue preserved over the periosteum, Zone 2 was prepared as a 3 mm wide periosteal bed by removing the overlying connective tissue, while Zone 3 consisted of a 2–3 mm apical area with thicker connective tissue preserved for graft stabilization. The mobilized mucosal flap was thinned and sutured to the apical portion of the recipient bed using 7-0 resorbable sutures.
A single epithelialized palatal strip graft, approximately 3 mm wide and 1 mm thick, was harvested from the palate using a 15C blade. The donor site was closed with criss-cross 6-0 polypropylene sutures without additional dressing or surgical stent. The graft was positioned over Zone 2 and initially stabilized at both extremities with periosteum-anchored interrupted sutures, followed by compressive horizontal mattress sutures engaging the connective tissue in Zones 1 and 3 to maintain close contact with the periosteal bed without perforating the graft.
The exposed connective tissue in Zone 1 remained between the existing coronal KT and the palatal graft, which may favor keratinocyte repopulation and contribute to additional KT gain beyond the original graft dimensions.
Results: Uneventful healing was observed in all three cases, with increased attached KT and vestibular depth at the treated sites. Additional keratinization coronal to the graft was observed during healing. Palatal donor sites showed complete epithelialization within 2 weeks, with mild postoperative pain limited mainly to the first 2 days and no delayed bleeding reported. Patients were satisfied with the clinical outcomes.
Conclusion: The mPSG technique may provide an alternative for KT augmentation around teeth using a single narrow palatal graft without additional biomaterials, with limited donor-site morbidity.
Topic: Peri-implant soft tissue
Authors: Aellos F, Clavelier A, Liu B, Wan A, Salvi GE, Romandini M, Helms JA
Title: Soft-Tissue Integration of Dental Implants: Formation, Maintenance, and Relevance for Peri-Implant Health
Source: J Periodontal Res. 2026 Mar 26
DOI: 10.1111/jre.70091
Reviewer: John Kerns
Type: Narrative Review
Keywords: peri-implant epithelium (PIE), junctional epithelium, hemidesmosome, keratinized mucosa
Purpose: To summarize the development, maturation, and determinants of peri-implant soft tissues, and to review the effect of soft-tissue phenotype to peri-implant diseases and soft-tissue dehiscence.
Discussion: The early soft-tissue implant interface is ore prone to disruption by probing and, presumably, abutment removal. This is due to the early implant healing stages.
First, the peri-implant soft tissue is recognized by a visible delineation between the peri-implant epithelium and adjacent oral epithelium. Histologically, as seen as early as day three, this corresponds with the formation of a coagulum/blood clot, which stabilizes the influx inflammatory cells, e.g. macrophages and neutrophils. Extensive apoptosis also occurs within the epithelial and connective tissue compartments. This lasts ~72 hours.
Then, the proliferation of gingival epithelial cells at the wound edge occurs. Clinically, this is seen by re-epithelialization and a color change in the peri-implant mucosa. Of note, this re-epithelialization is not the same as reattachment: The PIE lacks hemidesmosomes, e.g. laminin-5. A biological micro-gap is thus present and permits bacterial penetration. Interleukins and Tissue Inhibitors of Metalloproteinases (TIMP) are present. This occurs within days 3-7.
Finally, connective tissue healing occurs when inflammatory cells are significantly reduces. Nevertheless, T-cells, B-cells, and macrophages all remain elevated for at least four weeks. A proliferation of fibroblasts coincides a shift from inflammation to repair. Elastin fibers and collagen fibers are only gradually introduced (vs. relative abundance in the periodontium around teeth). Collagen fibers run parallel or circumferentially to the implant, adapting to the contours of the abutment but not forming a structural attachment. Thus, the peri-implant mucosa is more susceptible to apical displacement and inflammation than the periodontal tissues of a natural tooth.
Once tissue maturation has occurred, the PIE has never been shown to have true attachment to the implant. However, for hemidesmosomes to be created, the PIE (at the abutment/restoration interface) must remain non-keratinized. Similarly, the connective tissue portion has also never been shown to have true attachment; rather, the seal is mechanical and depends on tissue tone and elasticity. On the other hand, keratinization refers to the resiliency of the external layer of flattened epithelial cells to protect against abrasion, shear forces, and chemical and bacterial agents. Thus, the oral epithelium is optimally keratinized.
Regarding supracrestal soft tissue height, a healthy peri-implant mucosa and supracrestal soft tissue height is 3-4mm. However, no conclusive clinical data demonstrates a direct relationship between supracrestal soft tissue height and increased risk with peri-implant disease.
The concept of “one abutment, one time” is based on the dental implant and its final abutment being placed during the same surgical procedure so that peri-implant soft tissues are minimally manipulated to preserve the mucosal interface. It is reasonable to assume that repeated removal and reconnection of the abutments would disrupt the epithelial continuity and predispose the site to inflammation. Nevertheless, the maximum benefit thus documented is 0.2-0.5mm.
Interestingly, inflammation is a consistent feature in peri-implant mucosa, leading to almost ubiquitous bleeding on probing. Of note, a thinner soft-tissue phenotype may offer less resistance to probe penetration, potentially leading to an overestimation of peri-implant inflammation assessed by bleeding on probing. Soft-tissue phenotype is not purely a passive modifier of disease severity, but an active determinant of the barrier competence, inflammatory regulation, and susceptibility to peri-implantitis and soft-tissue dehiscence.
Conclusion: The durability of implants depends on the formation and maintenance of a stable soft tissue integration at the implant surface.
Topic: Autogenous bone grafting
Authors: Palombo D, Ríos-Barbero J, Conforti T, Chiapasco M
Title: Autologous Bone for Periodontal and Craniofacial Regeneration: Donor Sites, Characteristics and Indications
Source: J Periodontal Res. 2026 Jan 28
DOI: 10.1111/jre.70065
Reviewer: John Kerns
Type: Narrative Review
Keywords: autogenous bone, harvesting, autogenous harvesting morbidity, donor sites
Purpose: To evaluate the biological basis and clinical indications for contemporary use of autogenous bone in oral reconstruction and bone augmentation. A detailed overview of harvesting techniques and step-by-step protocols are also included.
Discussion: Cancellous bone has a higher osteogenic potential, as it increases the graft capacity to retain living bone cells during the earliest phases of healing, when nourishment is provided to the graft through plasmatic circulation from the surrounding tissue. It also permits faster ossification and revascularization into the recipient site. However, it is more prone to remodeling, especially from the endochondral origin, e.g. the anterior iliac crest.
Cortical grafts are more solid and compact and are organized in osteons, interstitial lamellae, and circumferential lamellae. These grafts have a slower graft integration and reduced osteogenic potential but provide superior mechanical stability.
Harvesting techniques include piezo instrumentation and bone scrapers, which give graft volumes of less than 5cc. When autogenous grafting particles are used, smaller particles sizes reduce mechanical stability and increase osteoclastic activity, facilitating more rapid replacement of the graft with vital bone. However, overly compacted particles may restrict cellular migration, potentially inhibiting angiogenesis. Autogenous bone graft particles from 0.5mm to 2mm are preferable.
Donor sites include the ramus, symphysis, tuberosity, iliac crest, and the parietal calvaria. Ramus grafting is typically cortical bone and has the lowest morbidity with IAN disturbance of 0.5%. Transient trismus and sensory disturbances may occur, though long-term sensory disturbances are rare. The symphysis is less optimal due to increased morbidity, including from early mental nerve paresthesia (9.6-62% incidence) and long-term nerve paresthesia (0-13.5%). Changes in chin contour have also been noted by patients. When harvesting from the symphysis region, it is recommended to limit access incisions to the canine region to minimize risk of mental nerve injury. The maxillary tuberosity has a thin cortical shell and sparse trabeculae with large marrow spaces. Mandibular and maxillary tori may also serve as sites for obtaining dense cortical bone.
For extra-oral grafting, the anterior iliac crest is the most common and voluminous extraoral donor site for autogenous bone harvesting. It contains very high concentrations of osteoprogenitor cells , though it has greater remodeling and increased risk of peri-implant bone resorption over time and may lead to gait disturbances, chronic donor site pain, and paresthesia of the overlying skin. Other extra-oral sites include the parietal calvarium, a common alternative to the iliac crest, and the proximal tibia, which contains dense cortical bone, highly cellular cancellous bone, but also often adipose tissue. Notably, the use of extra-oral autogenous bone placed in direct contact with the root surface may lead to ankylosis.
Autogenous bone is the gold standard for severe ridge defects, usually combined with deproteinized bovine bone material, with ratios of 50%/50% (especially in sinus augmentation), 20:80 autogenous: xenograft ratio, or DBBM sandwich (30:70 autogenous/DBBM). Vertical gains up to 6.4mm and horizontal gains up to 10.3mm with a CAD/CAM titanium mesh or a titanium-reinforced PTFE membrane, respectively, have been documented.
A detailed evidence and experience-based decision algorithm is included.
Conclusion: Intraoral donor sites offer low morbidity and high patient acceptance, while extraoral sites remain suitable alternatives for extensive reconstructions. Complications are generally infrequent and managed well. Autogenous bone remains a cornerstone of modern regenerative therapy, offering predictable outcomes, high implant survival rates, and excellent functional and esthetic results.
Topic: Penicillin allergy
Author:Fetner A, Vilela N, Lu X, Shan G, Duarte P
TitleSelf-Reported Penicillin Allergy, Alternative Antibiotics, and Implant Outcomes: A Retrospective Study
Source: Clinical Implant Dentistry and Related Research, 2026; 28: e70169
DOI: 10.1111/cid.70169
Type: Retrospective study
Reviewer: Pankti Rana
Keywords: antibiotics; penicillin; implants; complications; implant failure
Purpose: To investigate whether self-reported penicillin allergy and the use of alternative antibiotics are associated with postoperative surgical complications, early implant failure, and preloading crestal bone loss (PLCBL).
Materials/Methods: A total of 179 patients and 374 implants were included, with 59 patients reporting a penicillin allergy and 120 patients without a reported allergy. Patient, implant, and site-related variables were collected, including medical history, implant characteristics, and antibiotic prescriptions (penicillin/amoxicillin, clindamycin, azithromycin, or other antibiotics). Implant outcomes were assessed through clinical examinations and radiographic measurements. PLCBL was defined as >/= 0.5mm reduction in interproximal crestal bone level from placement to uncovery or crown delivery. Early implant failure, postoperative surgical complications, and PLCBL were evaluated using statistical analysis.
Results: A significantly higher rate of post-operative surgical complications (15.5% vs. 3.1%) and early implant failure (12.8% vs. 1.8%) were noted among patients reporting penicillin allergy compared with those without a reported allergy. However, self-reported penicillin allergy was not independently associated with any of the three implant outcomes and was not identified as an independent risk factor. No differences in PLCBL were observed between the two groups or between different types of antibiotics. Azithromycin was associated with a higher number of complications compared to the group prescribed with penicillin (20.8% vs 3.2%). Azithromycin and clindamycin were also associated with higher early implant failure rate compared to penicillin (20.8% and 8.3% vs 1.6%); however, the results were not statistically significant after regression analysis. Additionally, tissue-level implants demonstrated significantly lower odds of PLCBL compared with bone-level implants.
Conclusion: Self-reported penicillin allergy was not independently associated with early dental implant complications, implant failure, or crestal bone loss. However, certain alternative antibiotics, particularly azithromycin, were associated with increased postoperative surgical complications.
Topic: Sinus Elevation
Author: Menini M, Canullo L, Pesce P, Bixio F, Bagnasco F, Del Fabbro M
Title: Patient-Reported Outcome Measures (PROMs) in Sinus Elevation Procedures: A Systematic Review and Meta-analysis.
Source: Int J Oral Maxillofac Implants. 2026 Sep 30;41(5):557-566
DOI: 10.11607/jomi.11434
Type: Systematic review
Reviewer: Pankti Rana
Keywords: sinus elevation; bone graft; postoperative discomfort; meta-analysis
Purpose: To compare patient-reported outcome measures (PROMs) following different maxillary sinus elevation techniques and grafting protocols.
Materials/Methods: This systematic review and meta-analysis searched for randomized and comparative clinical trials evaluating PROMs after sinus floor elevation (SFE). 12 studies (11 RCTs and 1 non-RCT) were included in the review, with eight included in the meta-analysis. Postoperative pain during the first seven days was the primary outcome, and secondary outcomes included bleeding, medication use, swelling, oral function, patient satisfaction, and quality of life.
Results: Graftless SFE in the transcrestal group was associated with significantly less postoperative pain on days three and seven compared to SFE without grafting materials. Lateral SFE with and without grafting did not show significant difference in postoperative pain. No significant difference was observed on day one in both approaches. When comparing surgical approaches, transcrestal sinus floor elevation resulted in significantly less pain than the lateral approach on day one and three. The transcrestal technique was also associated with fewer postoperative symptoms, including swelling, edema, nasal discharge, and bleeding. Some studies also reported eating and sleep disturbances in patients receiving grafting materials. No significant difference in pain was identified between short implants and lateral sinus floor elevation at day seven.
Conclusion: Graftless sinus elevation and the transcrestal approach may reduce postoperative pain and discomfort compared with grafted and lateral SFE. However, available data is limited.
Topic: SCTG vs. GBR for Peri-Implant Buccal Dehiscence Treatment
Authors: Zuercher AN, Rusch F, Strauss FJ, Jung RE, Lim HC, Thoma D.
Title: Treatment of Small Peri-Implant Buccal Dehiscence Defects With SCTG or GBR: 3-Year Results of a Pilot Study.
Source: Clinical Implant Dentistry and Related Research, 2026.
DOI: 10.1111/cid.70192.
Type: Pilot Study
Reviewer: Malon Stratton
Keywords: dental implants, buccal bone dehiscence, connective tissue graft, guided bone regeneration
Purpose: This study compared SCTG and GBR for treating small (≤3 mm) buccal bone dehiscences during single implant placement, evaluating outcomes 3 years after loading. The aim was to determine whether the soft-tissue benefits of SCTG observed at 1 year persisted long-term.
Materials and Methods: This three-year follow-up of an exploratory randomized controlled trial evaluated adult patients receiving a single implant in the posterior maxilla or mandible. Eligible participants demonstrated low inflammation, defined by full-mouth plaque and bleeding scores below 25% and probing depths under 4 mm, and had at least one adjacent tooth as well as opposing dentition. OsseoSpeed EV implants (Dentsply Sirona) were placed using 3.6 mm implants at premolar sites and 4.2 mm implants at molar sites, while intraoperatively recording buccal defect height from the implant shoulder to the most coronal aspect of the buccal bone using a periodontal probe. All implants underwent 3 to 6 months of transmucosal healing before being restored with screw-retained monolithic multilayered zirconia crowns bonded to Titanium Base EV abutments fabricated from conventional impressions. Clinical and radiographic evaluations occurred at baseline (7 to 10 days post-crown delivery) as well as 1 and 3 years following functional loading. The primary outcome, buccal contour change, was evaluated at 1 mm and 3 mm below the mucosal margin. Horizontal tissue width changes were simultaneously calculated on bucco-oral cross-sections through the long axis of the implant. Secondary outcomes included specific clinical parameters such as probing depth (PD), bleeding on probing (BOP), and plaque control record registered across 6 sites per implant, alongside mid-facial keratinized mucosa width, as well as patient-reported oral health-related quality of life. Additionally, researchers used CBCT and STL data to measure buccal bone thickness at the implant shoulder, and at 1 mm and 3 mm apically while mesial and distal marginal bone levels were analyzed.
Results: Of the 28 patients initially evaluated, 16 completed the 3-year follow-up and were allocated to three treatment groups: subepithelial connective tissue graft (5 patients), guided bone regeneration (6 patients), and control (5 patients). The SCTG group demonstrated a significant increase in tissue contour during the first year, whereas the GBR group did not. From years 1 to 3, contour changes were minimal across all groups, indicating that the soft-tissue volume gained with SCTG was largely maintained. Horizontal tissue width also remained stable. Peri-implant clinical parameters, including PD, BOP, and plaque scores, remained stable across all groups throughout the 3-year follow-up. Most tissue remodeling appeared to occur during the first year, with greater contour changes in GBR sites potentially related to graft resorption following initial over-augmentation. Despite favorable soft-tissue outcomes with SCTG, hard-tissue augmentation may still be necessary when buccal bone is deficient, as this study did not evaluate the long-term impact of untreated bone defects on peri-implantitis risk. Marginal bone levels remained stable, and patient-reported quality of life did not differ significantly between groups.
Conclusions: Both SCTG and GBR resulted in stable buccal tissue contours and favorable peri-implant health over 3 years in patients with small (≤3 mm) buccal dehiscences who maintained good plaque control and attended supportive care visits. SCTG provided significant contour improvement during the first year, which was largely maintained through year 3. Further adequately powered randomized controlled trials with longer follow-up are needed to validate these findings and determine whether soft-tissue augmentation alone provides protection comparable to hard-tissue augmentation.
Topic: Soft Tissue Augmentation Before or After Implant Placement
Authors: Zhang Y, Park SY, Yoo SH, et al.
Title: Effect of Crestal Soft-Tissue Augmentation Prior to or Simultaneously With Implant Placement on Peri-Implant Tissue Dimensions: Histological Outcomes of an Experimental In Vivo Study.
Source: Journal of Clinical Periodontology, 2026.
DOI: 10.1111/jcpe.70211.
Type: Experimental In Vivo Study
Reviewer: Malon Stratton
Keywords: dental implants, soft tissue augmentation, connective tissue graft, implant placement
Purpose: The purpose of this study was to evaluate the effects of soft tissue augmentation timing and graft material on peri-implant soft-tissue dimensions using histologic analysis.
Materials and Methods: The study included six healthy male beagle dogs with 36 implant sites, randomly assigned using a split-mouth design (six implants per group). At Week 0, the mandibular first through third molars were hemisected and extracted bilaterally. In the staged (flapless) approach, soft-tissue augmentation was performed at Week 8, followed by flapless implant placement at Week 16. The groups included autogenous subepithelial connective tissue graft (SCTG), xenogeneic collagen matrix of similar dimensions, and a non-augmented negative control. Grafts were secured with metal pins. Implants were placed using a tissue punch and bone sounding, with placement depth determined by crestal bone level, transmucosal collar height, and soft-tissue thickness. In the simultaneous (flapped) approach, full-thickness buccal and lingual flaps were elevated through a mid-crestal incision at Week 16, and implants were placed at crestal bone level. The groups included simultaneous SCTG, simultaneous collagen matrix, and a non-augmented negative control. Both graft materials were secured to the buccal flap using the healing abutment. All sites received tissue-level implants (3.5 × 7 mm) with 4.0-mm-diameter, 5-mm-high healing abutments. Flaps were sutured around the healing abutments using resorbable monofilament sutures. All implants healed transmucosally without loading, and placement was confirmed radiographically. Postoperative medications included meloxicam and cephalexin for 7 days following each surgery. Sutures were removed after 7 days. Animals were sacrificed at Week 36, corresponding to 20 weeks after implant placement, and block specimens were collected for histologic analysis.
Results: Staged SCTG augmentation produced the greatest supracrestal tissue dimensions, with the advantage most evident on the lingual aspect. Supracrestal tissue height was highest in SCTG + flapless approach on both the buccal (3.92) and lingual (3.76) aspects. The xenogeneic collagen matrix also increased tissue dimensions, although the effect was generally smaller than with SCTG. Overall, grafted sites tended to have greater soft-tissue dimensions than non-grafted sites, particularly lingually. Staged flapless augmentation also showed numerically better outcomes than simultaneous open-flap grafting. Augmenting soft tissue before implant placement may help minimize early bone remodeling, particularly in sites with mucosal thickness below 2 mm or supracrestal tissue height below 3 mm. SCTG provides predictable integration and greater tissue thickness but requires a palatal donor site, increasing morbidity. Collagen matrices offer a less invasive alternative but generally provide smaller thickness gains (0.9–1.2 mm vs. 1.2–1.6 mm with SCTG) and greater volume contraction, while reducing surgical time, pain, and donor-site morbidity. Flapless placement preserves the periosteum and mucogingival junction, whereas flap elevation may disrupt these structures. The authors also noted greater differences between treatment groups lingually, potentially because buccal tissues are more susceptible to flap displacement, muscle pull, and anatomical variation.
Conclusions: In this canine model, staged SCTG followed by flapless implant placement (AFL) produced the greatest peri-implant soft-tissue dimensions, with significant improvements primarily on the lingual aspect. SCTG resulted in greater lingual supracrestal and transmucosal tissue height than the collagen matrix, which produced smaller gains. Although staged augmentation showed more favorable outcomes than simultaneous grafting, differences between flapless and flapped approaches were not statistically significant.
Topic: Peri-implantitis Risk Factors
Author: Ferrarotti, et al.
Title: Residual Periodontal Pockets at Implant Placement as Risk Indicator for Peri-Implantitis: A Systematic Review.
Source: Clin Implant Dent Relat Res. 2026 Aug;28(4):e70174
DOI: 10.1111/cid.70174
Reviewer: Ryan Higgins
Type: Systematic Review
Keywords: dental implants, furcation involvement, peri-implantitis, periodontitis, residual periodontal pockets, risk factors, supportive periodontal therapy.
Purpose: To determine if there is an increased risk of developing peri-implantitis in patients undergoing implant therapy that have residual periodontal pockets (PPD) after active periodontal treatment.
Materials and Methods: An electronic search of major databases was completed with studies that had residual PPD or furcation involvement recorded in patients that received at least one dental implant. The primary study outcome investigated was the incidence of peri-implantitis in these patients with residual PPDs. The definition of peri-implantitis used for these studies varied and none included the 2017 World Workshop definition. All definitions included a combination of PPD, BOP and/or suppuration, RBL. The range of residual PPD threshold was >/=3mm to >/=6mm depending on the study.
Results: From the data base search, there were 4 cohort studies that met the inclusion criteria. Each study had between 70-100 patients with 165 – 260 implants included. These studies had a follow-up time ranging from 1 to 23 years.
All four studies included found that patients had an increased peri-implantitis occurrence. When patients had teeth with PPD >/=5mm or >/= 6mm along with a greater number of these deeper PD sites, a greater risk of peri-implantitis was found. A secondary finding of one study included found that when these inflamed sites were directly adjacent to the implant site there was a greater risk of per-implantitis.
Discussion: Vagia et al. found that 11 patients and 14 implants had peri-implantitis (out of 86 patients and 260 implants). Of those 9/11 patients (12/14 implants) belonged to patients belonged to the residual pocket group (50/86 patients were in residual pocket group). This group found that the increased number of sites with PPD > 3mm showed an increased peri-implantitis risk. Pjetursson et al. found that patients with 4.1 residual PPD >/=5mm compared to 1.9 or less had greater peri-implantitis risk. Kumar et al. found an OR of 8.0 in peri-implantitis occurrence in patients with gingivitis or periodontitis in adjacent teeth at the time of implant placement. Zhang et al. found an HR = 6.71 for peri-implantitis occurrence in patients with >10% of sites with PPD >/=6mm at implant placement.
Conclusions: In patients with previously treated periodontitis with residual deeper PPD’s there is an increased risk of peri-implantitis.
Topic: Implant Crowns on Adjacent Teeth
Author: Shao, et al.
Title: The Long-Term Impact of Single Implant-Supported Crowns on Adjacent Natural Teeth: A Retrospective Longitudinal Study
Source: Clin Oral Implants Res. 2026 Sep 24.
DOI: 10.1111/clr.70180
Reviewer: Ryan Higgins
Type: Retrospective Longitudinal Study
Keywords: adjacent teeth, caries, complications, dental implants, tooth loss
Purpose: To observe the affect that single implant-supported crowns have on the health status of natural adjacent teeth long-term.
Materials and Methods: In the study 456 patients included that had single unit implants with crowns. Teeth adjacent to the single unit implant were compared against three intra-patient controls (same teeth in each of the other three quadrants). Data analyzed included caries rates, new restorations, tooth loss. The study included time points of 1-5 years (short term) after crown delivery and 5-15 years (long term) after crown delivery.
Results: Short term the average follow up was 3.88 years, while long term was 8.90 years. 456 patients were included in the short-term analysis while 180 patients were included in the long term. 11.6% of patients had diabetes mellitus, 42.5% had a history of periodontitis, 14% had previous orthodontic treatment, 21.5% had bruxism, 9% were former smokers, 20.8% were current smokers, and 70.2% were never smokers. Implant sites were 51.8% molars, 33.8% premolars, and 14.5% anterior. A delayed approach took place for 88.6% of implants. Non submerged healing was used for 68.0%. 39.9% of implants required bone grafting at time of placement. 76.3% of implants had a diameter >/= 3.75mm to 5mm, and 87.7% were >/= 10mm to 13mm in length. 80.3% of implants were bone-level.
Overall, it was found that teeth adjacent to implants had significantly higher overall complication rates when compared to the control quadrants. For the short term there was an 8% complication rate compared 2.2-2.7% in control with OR = 2.92-3.65. In the long-term follow-up, there was a 15% complication rate compared to 6.4-7.8% in control with OR = 2.16-2.57. In the short-term group, the greatest complication for the mesial and distal tooth was caries (OR = 3.60 mesial short term, OR = 11.13/13.51 in short/long term of distal tooth). For the distal tooth, there was an increased incidence of tooth loss (1.31% vs. 0.22-0.55%). A greater number of teeth both mesial and distal, required a greater need for restorations (4.71% short term, 9.17% long term compared to 1.21-1.43% and 3.06-3.33% in control).
For implant types, bone-level (OR=.44) and narrow-diameter (OR=.23) were found to be protective factors with a lower incidence of complication as, was pre-existing ortho, treatment (OR=.20). Bruxism (OR = 5.78), male gender (OR=10.88) on the other hand were found to have increased complications.
Conclusions: When comparing teeth with natural dentition adjacent to teeth adjacent to single unit implant crowns there is higher incidence in the long term of new restorations needed, caries found, and in the short-term tooth loss of the distal tooth.
Topic: Biologics for Maxillary Sinus Augmentation
Authors: Aghaloo T, et al.
Title: Application of Biologics in Maxillary Sinus Augmentation Surgery: A Narrative Review
Source: Clinical Implant Dentistry and Related Research, 2025; 27:e70004
DOI: 10.1111/cid.70004
Reviewer: Nicolas Lobo
Type: Review
Keywords: autologous blood concentrates, enamel matrix derivative, lateral window technique, maxillary sinus floor augmentation, recombinant platelet- derived growth factor, transcrestal technique
Purpose: To provide a comprehensive narrative review of the use of biologics in maxillary sinus floor augmentation (MSFA) surgery, summarizing, interpreting, and critiquing the available literature.
Discussion: In MSFA, biologics may improve healing, reduce morbidity and complications, and enhance clinical outcomes. Their mechanisms include anti-inflammatory, proliferative, chemotactic, angiogenic, antimicrobial, osteoconductive, and osteoinductive effects. These properties may accelerate healing and improve both clinical and patient-reported outcomes.
Autologous Blood Concentrates (ABC): Platelet rich fibrin (PRF) is a second-generation ABC that forms a fibrin scaffold rich in platelets, leukocytes, stem cells, and growth factors, allowing sustained growth factor release. PRF also has antimicrobial, anti-inflammatory, and immunoregulatory properties that may enhance healing and reduce bleeding. PRF preparation is simple, with variants including S-PRF, A-PRF, A-PRF+, and i-PRF. ABCs may accelerate healing, improve graft integration, and reduce postoperative discomfort, although results are inconsistent.
In MSFA, ABCs have been used alone, with graft materials, for membrane repair, window closure, and soft tissue healing. Clinical studies report favorable bone gain and high implant survival when ABCs are used alone. When combined with grafts, ABCs may enhance healing but often require biomaterials for space maintenance. PRF has been effective for Schneiderian membrane repair and may reduce complications while supporting osseointegration and soft tissue healing.
Crestal Approach: PRGF achieved similar bone gain with or without grafts, with implant survival rates of 96.7% at 1 year and 97.6% at 5 years. Marginal bone levels remained stable, and complications were uncommon.
L-PRF is the most studied autologous blood concentrate, with reported bone gain of 2.6-8.2 mm, typically 3-4 mm. Compared with ABBM in lateral window MSFA, L-PRF in transcrestal MSFA produced less bone gain but adequate clinical outcomes. L-PRF was associated with less postoperative pain and swelling. Current evidence supports predictable 3-4 mm bone gain, high implant survival, and low complication rates with L-PRF.
Lateral approach: ABCs used alone in lateral window MSFA showed uneventful healing, 3.4-10.4 mm bone gain, and 100% implant survival. ABCs were also used for membrane perforation repair and lateral window coverage, with stable long-term bone gain. Histology demonstrated ~33% vital, well-vascularized bone. Adding L-PRF improved implant stability but did not increase vital bone formation.
ABCs appear effective as the sole graft when implants are placed simultaneously, despite lower bone gain than traditional grafts. When implants are delayed, bone substitutes are recommended due to the limited mechanical stability of ABCs.
PDGF: promotes wound healing, angiogenesis, cell migration, and bone regeneration.
rhPDGF-BB is the most studied isoform and can be used in periodontal defects and gingival recession. Preclinical studies showed increased bone formation and bone-to-implant contact with rhPDGF-BB. In animal models, rhPDGF-BB combined with xenografts or β-TCP improved bone quality and quantity versus grafts alone.
In MSFA, rhPDGF-BB + xenograft produced more vital bone and less residual graft at 4-5 months, but differences disappeared by 7-9 months. Evidence suggests rhPDGF-BB may enhance early bone formation, but long-term benefits remain unclear.
BMP-2 is an osteoinductive growth factor that promotes bone formation by stimulating stem cell recruitment and osteoblast differentiation. Can be use in MSFA and alveolar ridge augmentation. Clinical studies show predictable new bone formation, but no consistent advantage over autografts, allografts, or xenografts in bone formation or implant survival. Compared with allografts, rhBMP-2 yields similar vital bone with greater early bone height and volume; these benefits decrease over time. Compared with autografts, rhBMP-2 results in lower bone height and density after 6 months. Use with graft materials shows mixed results, although animal studies suggest enhanced bone formation. A concentration of 1.5 mg/mL is commonly used and effective. Adverse effects are usually mild, including pain, swelling, and erythema; serious complications are rare. rhBMP-2 supports predictable bone regeneration, but evidence does not show clear superiority over conventional grafts.
EMD is osteoconductive and osteopromotive, enhancing osteoblast activity, wound healing, tissue regeneration, and stem cell proliferation. Used for intrabony defects with positive periodontal regeneration outcomes, but results in ridge preservation are inconsistent.
Few MSFA studies exist: one showed greater new bone formation with EMD + ABB versus ABB alone, while another found no benefit with a synthetic graft. Preclinical data suggest improved vascularity and bone protein expression, but clinical evidence for sinus augmentation remains limited.
Conclusions: Growth factors are used in regenerative and implant dentistry to enhance healing and tissue regeneration. rhPDGF-BB, rhBMP-2, and ABCs have shown promising regenerative outcomes. As their use expands, applications in implant therapy are expected to increase.
Topic: Palatal wound healing
Authors: Yineman K, et al.
Title: Palatal donor site wound healing following mucogingival surgery using amnion–chorion membrane: A randomized controlled clinical trial
Source: J Periodontol. 2026;97:1900–1909
DOI: 10.1002/jper.70147
Reviewer: Nicolas Lobo
Type: RCT
Keywords: amnion, biological dressings, chorion, palate, tissue grafts, wound healing
Purpose: To compare palatal donor-site wound healing after free gingival graft harvesting using an amnion-chorion membrane (ACM) dressing versus a hemostatic agent (HA), and to assess postoperative pain and analgesic use during the first 72 hours.
Materials and Methods: Patients requiring a soft tissue autograft were enrolled. Exclusion criteria included uncontrolled systemic disease, immunosuppression, chronic steroid use, and pregnancy. Medical history, anticipated pain, and maxillary impressions for palatal stent fabrication were obtained before surgery. Patients were randomized to receive either ACM (test) or HA (control) at the palatal donor site following soft tissue harvest. The wound dressing was sutured in place, and a palatal stent was delivered. Patients were prescribed analgesics and NSAIDs after surgery and for at least the first 3 days postoperatively. Pain levels and analgesic consumption were recorded at 24, 48, and 72 hours after surgery. Palatal wound healing was evaluated weekly for 4 weeks using the Early Healing Index (EHI), assessing bleeding, epithelialization, inflammation, granulation tissue, and redness. Postoperative bleeding events requiring intervention were also recorded.
Results: 73 patients (36 ACM, 37 HA). No significant differences were found between groups in age, sex, smoking status, or diabetes status. 89 grafts were harvested (45 ACM, 44 HA). No significant differences were found between groups in graft dimensions, graft thickness, or preoperative palatal thickness.
EHI scores improved significantly from weeks 1-4 in both groups, with no significant differences at any individual time point. After adjusting for covariates, ACM showed slightly higher overall EHI scores than HA. Older age was associated with better healing, while graft dimensions and palatal thickness had no significant effect.
No significant differences in pain scores were found between ACM and HA at 24, 48, or 72 hours. Pain decreased significantly over time in both groups. Pain was not associated with graft size, palatal thickness, sex, smoking status, or anticipated pain. Patients with diabetes reported less pain at 24 and 48 hours.
No significant differences in acetaminophen or ibuprofen use were found between ACM and HA groups. Analgesic consumption decreased over time, and the duration of postoperative analgesic use was similar between groups.
ACM provided a small but significant improvement in early palatal wound healing, particularly during the first 2 weeks. Pain, analgesic use, and healing were not influenced by graft size or thickness. Older patients showed slightly better healing, and postoperative bleeding was less frequent with ACM.
Conclusions: ACM slightly improved early palatal wound healing compared with HA during the first 4 weeks and may be beneficial for patients at risk of delayed healing.
Topic: Timing of Re-evaluation
Authors: Castelluzzo W., et. al.
Title: Timing of Re- Evaluation After Periodontal Therapy: A Randomized Clinical Trial
Source: Journal of Periodontal Research
DOI: 10.1111/jre.70086
Type: Randomized Clinical Trial
Reviewer: Mahya Sabour
Keywords: Periodontal disease, non-surgical therapy, re-evaluation
Purpose: to compare 3 and 6-month re-evaluation results after non-surgical periodontal therapy (NSPT) and assess how different variables influence endpoints of treatment (EoT).
Materials and Methods: Patients were diagnosed with stage III or IV periodontitis and had minimum 20 teeth present, with no history of treatment the year prior. Periodontal treatment was provided by 2nd and 3rd year periodontal residents at the University of Florence; each having treated at least 30 patients prior to the study.
Step 1 and 2 therapy: Oral hygiene instructions were provided and lifestyle habits that negatively influence periodontitis were addressed. Full mouth subgingival instrumentation with ultrasonics and mini Gracey curettes under 3-4x magnification was completed. Based on their group allocation, the patients were either seen for 2 maintenance appointments (3-month group) or 5 (6-month group) prior to a final maintenance at their re-evaluation time. If the full mouth plaque scores (FMPS) were >25% at these visits, oral hygiene techniques were asked to be demonstrated by the patient and corrected if required. The size of interdental brushes were also verified and adjusted.
Variables and radiographic assessment: EoT was defined as probing depths (PD)<6mm or PD of 4 or 5 without bleeding on probing (BOP). Deep pockets had minimum 1 site with PD>/=6mm and moderate pockets had a PD of 4 or 5 with BOP. Buccal roots were used for radiographic measurements on maxillary multirooted teeth. Infrabony defects were classified as deep if they had an infrabony component >/=3mm and shallow if <3mm. Defect angles were wide if >/=37° and narrow if <37°.
Results: 36 patients with 946 teeth were included in the study. The mean duration of the periodontal treatment was 143.2 minutes in the 6-month group and 139.5 in the control group with no significant difference (NSD).
Primary analysis: NSD between the variables in the two groups
The number of teeth that achieved EoT were 15.8 teeth (68.5% of sites) in the 3-month group and 15.5 (71.9% of sites) in the 6-month group. NSD was seen in the number of teeth with moderate or deep residual PDs between the groups. Both groups showed a reduction in FMPS, full mouth bleeding scores, PDs, and number of pockets, with an increase in recession. NSD was found in the oral health impact profile (OHIP-14) scores between the groups. NSD was noted in the PD reduction between the groups. Baseline PD>=6mm showed greater reduction in the 6-month group (2.6mm) vs. 3-months (2.3mm). Of these sites 49.8% in the 3-month group and 53.7% in the 6-month group achieved EoT (higher tendency in the 6-month group).
Secondary analysis: pooled results of both groups (671 teeth). Mean defect depth was 3.65mm, 107 being deep (>/=3mm) with a mean radiographic depth of 5.46mm. Regardless of the initial PD, deeper defects showed less chances of obtaining site-level EoT. If the initial PD was >/=7mm, shallow intrabony defects had less chances of obtaining EoT compared to Suprabony defects.
Factors that significantly increased chances of residual PDs were baseline PD (1.84 OR), plaque at the site at re-evaluation (1.47 OR), molar tooth (1.61 OR), Furcation involvement (2.12 OR), shallow intrabony defects (1.60 OR), deep intrabony defects (2.36 OR).
Conclusion: Clinical and patient-related outcomes were not different between 3- and 6-month re-evaluation groups. Both groups achieved 70% of sites with EoT. Although less healing was found in intrabony defects compared to Suprabony defects, if associated with shallow PDs, a non-negligible number of the infrabony defects can heal with NSPT alone.
Topic: Implant-related Complications
Authors: Mauland E.K., et al.
Title: Association Between Local Factors and Implant- Related Complications: A Population- Sampled Cross-Sectional Analysis
Source: Journal of Clinical Periodontology, 2026; 0:1–14
DOI: 10.1111/jcpe.70209
Type: Cross-sectional study
Reviewer: Mahya Sabour
Keywords: dental implants, peri-implant disease, patient outcomes
Purpose: to assess how local factors influence peri-implantitis and peri-implant soft tissue dehiscences (PISTD) 8 years after implant placement.
Materials and Methods: 241 patients with 732 implants were included for clinical and radiographic assessments. PISTD was measured as the distance from the mid-buccal soft tissue margin to the implant platform and considered present if it was >/=1mm apical to the platform.
Results: Peri-implantitis: 16.9% patient-level and 8.7% implant-level prevalence was noted. A significant association was noted with thin phenotype, platform level (bone level, external connection, platform matching), implant bridges (vs. single crowns), implant manufacturer, absence of adjacent teeth, and stage IV periodontitis / edentulism and factors confirmed by the final regression models: mucosal margin mobility, platform matched bone-level implants, emergence angle (EA) >45, anterior location, and smoking >/=10 cigarettes/d. In implant supporting bridges, peri-implantitis was associated with implants that were not end pillars.
PISTD: 34.6% patient-level and 25% implant-level prevalence was noted. Initial regression model showed a significant associated with mandibular implants, platform matching, implants supporting bridges, narrow keratinized tissue width, older age, , and periodontitis stage IV/edentulism, and factors confirmed by the final regression model: thin phenotype, mucosal margin mobility, absence of adjacent teeth, peri-implantitis, external connections.
Peri-implantitis and PISTD: 141 patients had neither, 53 only had PISTD, 12 patients only had peri-implantitis, and 28 patients had both.
Conclusion: This study found an association between local factors and peri-implantitis and PISTD, including soft tissue phenotype, EA, implant connection type, platform switching, anterior implants, and placement of adjacent teeth.
